Toshinaga Tsuji

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Major Depressive Disorder

Placebo Controlled

Top Venues

Neuropsychiatric disease and treatment

Neurology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Masaki Kato, Hiroshi Tsuda, Yirong Chen, Toshinaga Tsuji, Nobuhiro Nishigaki
The Burden of Attention-Deficit/Hyperactivity Disorder Traits in Adult Patients with Major Depressive Disorder in Japan. Neuropsychiatric disease and treatment 19 (2023)
Masaki Kato, Hiroshi Tsuda, Yirong Chen, Toshinaga Tsuji, Nobuhiro Nishigaki
The Burden of Attention-Deficit/Hyperactivity Disorder Traits in Adult Patients with Major Depressive Disorder in Japan. Neuropsychiatric disease and treatment 19 (2023)
Toru Nakai, Toshinaga Tsuji, Hiroshi Tsuda, Takuma Sotodate, Yuki Namba, Tatsuhiro Uenishi, Katsuhiko Iwasaki, Kinya Kokubo, Hiroaki Tomita
Working Conditions, Work Productivity, Quality of Life, and Depressive Symptoms in Undiagnosed Adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms During the COVID-19 Pandemic. Neuropsychiatric disease and treatment 18 (2022)
Noa Tsujii, Masahide Usami, Noriyuki Naya, Toshinaga Tsuji, Hirokazu Mishima, Junko Horie, Masakazu Fujiwara, Junzo Iida
Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review. Neurology and therapy 10 (2) (2021)
Chika Sakai, Toshinaga Tsuji, Toru Nakai, Yuki Namba, Hirokazu Mishima, Masakazu Fujiwara, Hisato Matsunaga
Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis. Neuropsychiatric disease and treatment 17 (2021)
Norio Sugawara, Yasui-Furukori Norio, Toshinaga Tsuji, Shinji Hayashi, Yoshikazu Ajisawa, Toshimitsu Ochiai, Hideyuki Imagawa, Kazutaka Shimoda
The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms. Neuropsychiatric disease and treatment 16 (2020)